title: Isoniazid preventive therapy in medium-incidence settings: the price is right.
authors.affiliation: Duke University Medical Center, Durham, NC, USA.
authors.forename: Jason E
authors.initials: JE
authors.lastname: Stout
authors.affiliation: Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: Jason R
authors.initials: JR
authors.lastname: Andrews
mesh_terms: D000995:Antitubercular Agents / Q000191:economics* / Q000627:therapeutic use*; D060085:Coinfection; D016527:Drug Costs; D015658:HIV Infections / Q000191:economics*; D006801:Humans; D007538:Isoniazid / Q000191:economics* / Q000627:therapeutic use*; D055985:Latent Tuberculosis / Q000188:drug therapy* / Q000191:economics*; D008403:Mass Screening / Q000191:economics*
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid